Asymptomatic autoimmune hepatitis associated with anti-LC-1 autoantibodies

Journal of Pediatric Gastroenterology and Nutrition

Volumn 23, Issue 4, 1996, Pages 461-465

  Klein, Christoph ^a,d   Philipp, Thomas ^b   Greiner, Peter ^a   Strobelt, Michael ^c   Müller, Herbert ^a   Trautwein, Christian ^b   Brandis, Matthias ^a   Manns, Michael ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; CHILD; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; FEMALE; HEPATOSPLENOMEGALY; HLA TYPING; HUMAN; HYPERGAMMAGLOBULINEMIA; LIVER BIOPSY; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL;

AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS; HUMANS; LIVER; MALE; MICROSOMES, LIVER; PREDNISONE;

EID: 0030460251     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199611000-00019     Document Type: Article

References (23)

1. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
2. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13:701-6.
3. Porta G, da Costa Gayotto LC, Alvarez F. Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure. J Pediatr Gastroenterol Nutr 1990;11:138-40.
4. Peeters S, Blecker U, De Valck J, et al. Asymptomatic autoimmune chronic active hepatitis in a male adolescent. Eur J Pediatr 1993;152:107-9.
5. Manns MP. Cytoplasmic autoantigens in autoimmune hepatitis: molecular analysis and clinical relevance. Semin Liver Dis 1994;11:205-14.
6. Mackay IR, Taft LI, Melb MD, Melb MB, Cowling DC. Lupoid hepatitis. Lancet 1956;2:1323-6.
7. Odièvre M, Maggiore G, Homberg JC, et al. Seroimmunologic classification of chronic active hepatitis in 57 children. Hepatology 1983;3:407-9.
8. Homberg JC, Abuaf N, Bernard O, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987;7:1333-9.
9. Codoner-Franch P, Bernard O, Maggiore G, Alagille D, Alvarez F. Clinical and immunological heterogeneity of anti-liver-microsome antibody-positive autoimmune hepatitis in children. J Pediatr Gastroenterol Nutr 1989;9:436-40.
10. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH. Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;1:292-4.
11. Martini E, Abuaf N, Cavalli F, et al. Antibody to liver cytosol (Anti-LC-1) in patients with autoimmune chronic active hepatitis type 2. Hepatology 1988;8:1662-6.
12. Abuaf N, Johanet C, Chretien P, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology 1992;16:892-8.
13. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. The major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989;83:1066-72.
14. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and applications. Proc Natl Acad Sci USA 1979;76:4350-4.
15. Durazzo M, Philipp T, van Pelt FNAM, et al. Heterogeneity of microsomal autoantibodies (LKM) in chronic hepatitis C and D virus infection. Gastroenterology 1996;108:455-62.
16. Manns MP, Griffin KJ, Quattrochi LC, et al. Identification of cytochrome P450IA2 as a human autoantigen. Arch Biochem Biophys 1990;280:229-32.
17. Maggiore G, Bernard O, Homberg JC, et al. Liver disease associated with anti-liver-kidney microsome antibody in children. J Pediatr 1986;108:399-404.
18. Sacher M, Blümel P, Thaler H, Manns M. Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. J Hepatol 1990;10: 364-9.
19. Beaune P, Dansette PM, Mansuy D, et al. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987;84:551-5.
20. Philipp T, Durazzo M, Trautwein C, et al. Recognition of uridine diphosphate glucuronosyl transferase by LKM-3 antibodies in chronic hepatitis D. Lancet 1994;344:578-81.
21. Lenzi M, Manotti P, Muratori L, Cataleta M, Ballardini G, Cassani F. Diagnostic relevance of LC1 antigen-antibody system in autoimmune hepatitis type 2. J Hepatol 1993;18 (suppl 1):4.
22. Han S, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology 1995;21: 58-62.
23. Vegnente A, Larcher VF, Mowat AP, Portman B, Williams R. Duration of chronic active hepatitis and the development of cirrhosis. Arch Dis Child 1984;59:330-5.